Br-Val-Ala-NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT
Modify Date: 2025-08-25 13:32:35
![Br-Val-Ala-NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT Structure](https://image.chemsrc.com/caspic/291/2857037-70-6.png)
Br-Val-Ala-NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT structure
|
Common Name | Br-Val-Ala-NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT | ||
|---|---|---|---|---|
| CAS Number | 2857037-70-6 | Molecular Weight | 764.62 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C36H38BrN5O9 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Br-Val-Ala-NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPTBr-Val-Ala-NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT (Formula V) is a drug-linker conjugate that composed of a potent topoisomerase I inhibitor and a linker to make antibody drug conjugate (ADC)[1]. |
| Name | Br-Val-Ala-NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT |
|---|
| Description | Br-Val-Ala-NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT (Formula V) is a drug-linker conjugate that composed of a potent topoisomerase I inhibitor and a linker to make antibody drug conjugate (ADC)[1]. |
|---|---|
| Related Catalog | |
| Target |
Drug-Linker Conjugates for ADC[1] |
| In Vitro | Br-Val-Ala-NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT 可以与抗 c-Met 抗体偶联形成抗 c-Met 拓扑异构酶 1 抑制剂抗体药物偶联物 (ADC)。 |
| References |
[1]. Phillips AC, et, al. Anti-c-met antibody drug conjugates. WO2022232834A1. |
| Molecular Formula | C36H38BrN5O9 |
|---|---|
| Molecular Weight | 764.62 |
| InChIKey | RCIVGZZPQGHOGN-XEXAXUILSA-N |
| SMILES | CCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1cc3c(cc1c2C12CC(NC(=O)C(C)NC(=O)C(NC(=O)CBr)C(C)C)(C1)C2)OCO3 |